Community-acquired Pneumonia IV or IM Pediatric patients ≥3 months of age with CAP caused by S. pneumoniae: 50–100 mg/kg daily as a single dose or in divided doses every 12 hours for penicillin-susceptible strains or 100 mg/kg daily as a single dose or in divided doses every 12 ...
Ceftriaxone, developed by Hoffmann-La Roche and patented in 1978, was approved by FDA in 1984 and marketed under the brand name Rocephin as a third-generation cephalosporin antibiotic to treat bacterial infections, exemplified by endocarditis, pneumonia, middle ear infections, skin infections, and uri...
pneumonia, community-acquired [1-2 g IM/IV q24h for at least 5 days] Info: for inpatient tx; refer to IDSA guidelines infections, uncomplicated gonococcal [treatment] Dose: 500 mg IM x1; Info: for pts <150 kg; give 1 g IM x1 if wt >150 kg; 1st-line agent; if chlamydial infe...
PEDIATRIC PATIENTS: For the treatment of skin and skin structure infections, the recommended total daily dose is 50 to 75 mg/kg given once a day (or in equally divided doses every 12 hours). The total daily dose should not exceed 2 grams. ...
Using Monte Carlo simulation, in a pediatric population with community-acquired pneumonia, a dose regimen of 100mg/kg every 24h produced satisfactory target attainment rates while remaining within the required minimum inhibitory concentration (2mg/L). Population pharmacokinetics of ceftriaxone was ...
The treatment of pneumonia in children: ceftriaxone vsamoxicillin plus tobramycin. An open trial. Clinical Trials Journal 22: 401–404, 1985 Google Scholar Rausis C, Amato M. Prevention of post-operative infections in general surgery: convenience of a single ceftriaxone dose. Proceedings of the ...
Twenty-six children received a single daily intravenous dose of ceftriaxone, 50 mg/kg, for a variety of bacterial infections including abscess (5), cellulitis (5), periorbital cellulitis (5), bacteremia without focus (4), osteomyelitis (2), pneumonia (2), pyelonephritis (2) and otitis medi...
In pediatric patients beyond the newborn period, larger doses appropriate for penicillin-resistant pneumococcal pneumonia. Current guidelines should be consulted for additional information.Usual Pediatric Dose for Joint Infection1 month or older: 50 to 75 mg/kg/day IV or IM in divided doses every ...
Background: Although the WHO still recommends ampicillin/benzyl penicillin for the treatment of severe pneumonia, the use of cephalosporins, particularly c... SC Singhi - 《Iapindia Org》 被引量: 0发表: 0年 Pharmacokinetics of Ceftriaxone in Pediatric Patients With Meningitis Pharmacokinetics of cef...
the reliability of 2 of these studies was compromised by use of comparator agents which may not have provided adequate antibacterial activity for the treatment of community-acquired pneumonia: the refore more studies are needed before any definitive conclusions can be drawn about the effect of ceftr...